![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 46, 32771-32777, November 12, 1999
From the We have shown that the domain V of bacterial 23 S
rRNA could fold denatured proteins to their active state. This segment
of 23 S rRNA could further be split into two parts. One part containing mainly the central loop of domain V could bind denatured human carbonic
anhydrase I stably. This association could be reversed by adding the
other part of domain V. The released enzyme was directed in such a way
by the central loop of domain V that it could now fold by itself to
active form. This agrees with our earlier observation that proteins
fold within the cell posttranslationally, a process that is completed
after release of the newly synthesized polypeptide from the ribosome
(Chattopadhyay, S., Pal, S., Chandra, S., Sarkar, D., and DasGupta, C. (1999) Biochim. Biophys. Acta 1429, 293-298).
We have identified the ribosome as a general protein folding
modulator on the basis of its ability to successfully fold all the
denatured proteins that we have tried so far (e.g. lactate dehydrogenase, glucose-6-phosphate dehydrogenase, horseradish peroxidase, restriction endonucleases, alkaline phosphatase, malate dehydrogenase, We identified the protein folding activity in the large loop of domain
V of 23 S rRNA of bacterial ribosome (4, 9, 10). We have reported in a
number of publications (1-6, 10) that the 70 S bacterial ribosomes,
the 80 S wheat germ and rat liver ribosomes, the 50 S bacterial
ribosomal subunit, its 23 S rRNA, as well as the
660-nt1 domain V of 23 S rRNA
could all fold denatured proteins, and at the end of the reaction they
were found to dissociate completely from the proteins without the
assistance of any co-factor. This implied that there were at least two
steps in these reactions: (a) interaction with unfolded
proteins to fold them and (b) dissociation from the folded
proteins. We took the 660-nt-long domain V RNA from Bacillus
subtilis and further split it into two smaller pieces that acted
in a particular sequence on the unfolded protein to fold it. Here we
present the role of these two parts of domain V in refolding denatured proteins.
Enzymes and Reagents--
Human carbonic anhydrase I (EC
4.2.1.1), pig muscle lactate dehydrogenase (EC 1.1.1.27), and porcine
heart cytoplasmic malate dehydrogenase (EC 1.1.1.37) were purchased
from Sigma. The enzymes gave single bands of monomeric molecular
weights 29,800, 31,000, and 35,000, respectively, in SDS-polyacrylamide
gel electrophoresis. These enzymes are referred to as carbonic
anhydrase, lactate dehydrogenase, and malate dehydrogenase in the text.
All the laboratory reagents used were of analytical grade.
Preparation of E. coli 50 S Ribosomal Particle and Its 23 S
rRNA--
Purification of 70 S ribosome, its 50 S subunit, and 23 S
rRNA from E. coli MRE 600 have been described previously
(6). The 23 S rRNA was separated from 5 S RNA by gel filtration. The purity of 23 S rRNA was checked by (a) electrophoresis in a
composite gel 0.5% agarose and 3% of a 19:1 (by mass) mixture of
acrylamide/N,N'-methylene bisacrylamide, (b) an
A260/A280 greater than
2.0, and (c) 40% hyperchromicity on RNase digestion at
37 °C.
Preparation of Domain V of 23 S rRNA and Its Segments from B. subtilis--
The 23 S rRNAs from many bacterial species including
E. coli and B. subtilis have identical secondary
structures where the nucleotides in the single-stranded region,
especially the central loop of domain V, are invariant. The nucleotides
can vary in the double-stranded regions from one bacterial species to
another, but the conformations remain the same. Therefore, we took the cloned domain V of B. subtilis 23 S rDNA because it has
convenient restriction sites that are lacking in the corresponding
region of the E. coli 23 S rDNA. The 660-nt-long domain V
RNA of B. subtilis, its 337-nt-long segment containing
mainly the central loop of domain V, and another 425-nt-long segment
from the 5' end were transcribed from plasmids pDK105 linearized with
SmaI, pDK106 linearized with EcoRI, and pDK105
linearized with SmaI, respectively. All the transcriptions
were done from SP6 promoter by SP6 RNA polymerase (Roche Molecular
Biochemicals). The plasmids pDK105 and pDK106 were kind gifts from B. Weisblum, Madison, WI. The DNA templates were digested with RNase-free
DNase I, and RNA was precipitated with ethanol after phenol extraction.
The amount of RNA synthesized was estimated by adding a trace amount of
[ Labeling Carbonic Anhydrase with Fluorescent Probe FITC--
The
enzyme (100 mM) was mixed with a 50-fold molar excess of
FITC at pH 8.7 and kept in ice for 1 h. The labeled enzyme was separated from unincorporated FITC by Sephadex G-25 gel filtration column. The enzyme activity did not change due to FITC labeling, and it
did not interfere with denaturation and refolding of the enzyme.
Fluorescence emission from FITC-labeled protein was obtained by
exciting at 495 nm and measuring emission at 520 nm using a Hitachi
F3010 fluorescence spectrophotometer. Fluorescence labeling of the
enzyme was necessary for its quantitation in experiments where the
amount of enzyme was so small that we could not use its activity,
A280, or intrinsic fluorescence of tryptophan
residues for quantitation.
Denaturation and Refolding of Enzymes--
Carbonic anhydrase
was denatured at a concentration of 10 µM with 6 M guanidine- hydrochloride for 2 h at 25 °C. The
protein lost its secondary structure as revealed by its CD spectrum.
For refolding, the denatured protein was diluted 100-fold (final
concentration: 100 nM) in a buffer containing 50 mM Tris-HCl (pH 7.6), 5 mM magnesium acetate,
and 200 mM NaCl and incubated at 25 °C for 30 min with or without folding modulators. The activity of refolded enzyme was
assayed by adding 500 µM para-nitrophenyl
acetate to the refolding mixture and measuring the increase in
A400 with time when incubated at 25 °C. The
concentrations of enzyme and ribosomal RNA, etc., varied in different
experiments and are mentioned in appropriate places. Lactate
dehydrogenase, a homotetrameric enzyme, was denatured at a
concentration of 3.2 µM with respect to monomer with 1 M guanidine hydrochloride at 20 °C for 1 h (9). For
refolding, the enzyme was diluted 100-fold in 20 mM
Tris-HCl, pH 7.5, 200 mM NaCl, and 4 mM
magnesium acetate and incubated at 20 °C for 30 min with or without
RNA (9). The enzyme concentration was 32 nM with respect to
monomer during refolding. Malate dehydrogenase, a homodimeric enzyme,
was denatured at a concentration of 1.15 µM with respect
to monomer with 6 M guanidine hydrochloride at 20 °C for
40 min. For refolding the denatured enzyme was diluted 80-fold in 25 mM sodium phosphate, pH 7.6, 200 mM NaCl, 5 mM 2 mercaptoethanol, and 4 mM magnesium
acetate and incubated at 20 °C for 15 min in the presence or absence
of RNA. The enzyme concentration during refolding was 14 nM
with respect to monomer. For all the enzymes, refolding was over by the
time of incubation mentioned above. The extent of refolding was
calculated by taking the ratio of the activity of the refolded enzyme
to the activity of the same amount of native enzyme.
Gel Retardation Assay for RNA Bound to the
Enzyme--
Linearized plasmid pDK106 was transcribed in presence of
[ Acrylamide Quenching Studies on Native, Spontaneously Folded,
RNA1-bound and RNA1/RNA2-mediated Folded Enzyme--
Steady state
fluorescence was measured using a Hitachi F 3010 spectrofluorimeter.
Quenching of fluorescence emission from tryptophan residues was
obtained by recording the intensities (excitation: 290 nm; emission:
330 nm) after successive addition of small aliquots of quencher
(acrylamide) stock solutions. A nominal bandpass of 5 nm for the
excitation and 5 nm for the emission was used. The fraction of
tryptophan residues that are accessible to the quencher molecule could
be estimated from the equation F0/(F0 The Folding of Denatured Proteins by 50 S Ribosomal Particle and
Domain V of Its 23 S rRNA--
Fig. 1
shows the refolding of three denatured enzymes, carbonic anhydrase
(monomer), malate dehydrogenase (homodimer), and lactate dehydrogenase
(homotetramer) with 50 S ribosomal subunit, its 23 S rRNA, and the
domain V of 23 S rRNA. The concentration of denatured enzymes were 100, 14, and 32 nM, respectively, with respect to monomer.
Although all of them could refold the denatured enzyme, there was a
gradual decrease in the extent of refolding as we went from 50 S
subunit to the domain V of its 23 S rRNA. This protein folding activity
was specific for domain V RNA. The 16 S rRNA, tRNA, and regions of 23 S
rRNA other than domain V (e.g. the domain II of 23 S rRNA)
did not show this activity (3, 4, 9). The activity could also be
destroyed by RNase (3, 4). As mentioned under "Discussion,"
although the domain V provides the crucial site for refolding (9, 10)
other regions of 23 S rRNA may also provide additional sites to
interact with denatured proteins to increase the yield of refolded
enzymes. However, the domain V appears to provide the minimum length of RNA that shows peptidyl transferase activity (13, 14) and protein
folding activity, which is sensitive to antibiotics that prevent
protein synthesis and folding in vitro and in
vivo (1, 10). Therefore, we turned our attention to the domain V
and went on to see if the active site(s) could be further narrowed down
to any part of it.
The increased activity of the refolded enzymes was not due to some
fortuitous effect of the ribosomes/the subunits and RNAs. The native
enzymes did not show any increase in activity in presence of any of the modulators.
The reduced ability of domain V RNA to fold protein compared with 50 S
particle could also be due to partial loss of its structure in absence
of ribosomal proteins. The 23 S RNA has been shown to lose its peptidyl
transferase activity due to deproteinization (13). It may also be
necessary to vary reaction conditions to optimize the protein folding
activity of domain V RNA.
It should also be mentioned here that ribosomes/ribosomal RNA refolds
some intermediate(s) of spontaneous folding of the enzyme since the
secondary and some tertiary structures are formed in the dead time of
dilution of denaturant.
Two Fragments of the Domain V of 23 S rRNA Complement to Fold
Denatured Proteins--
We took the 660-nucleotide-long domain V of
B. subtilis 23 S rRNA for this purpose. As mentioned under
"Experimental Procedures," it can be easily divided into two parts
with some overlap. One of them is a 337-nucleotide-long in
vitro transcript, obtained using EcoRI-cleaved pDK106
template, which possesses mainly the single stranded large circle of
domain V but lacks the elaborate stem loop part, which is deleted in
the cloned gene (kindly provided by Prof. B. Weisblum, University of
Wisconsin, Madison, WI). We call this RNA1. The other is transcribed
from plasmid pDK105 after cutting it with restriction endonuclease
SmaI. This gives a 425-nt-long RNA having mainly the
elaborate stem loop part toward the 5' end of domain V, but it lacks
most of the large circle. We call this RNA2. The putative secondary
structures of 660-, 337-, and 425-nt RNA are shown in Fig.
2 (15). Refolding of denatured carbonic anhydrase (100 nM), malate dehydrogenase (14 nM), and lactate dehydrogenase (32 nM) with
different concentration of the two RNA moieties mixed in 1:1 ratio are
shown in Fig. 3. The extent of refolding
was the same as that of refolding with 660-nt-long RNA (compare with
Fig. 1). Therefore, these two RNA molecules complement each other in
the refolding reaction. They either act independently on the unfolded
proteins (see below) or form a composite RNA through tertiary
interactions between themselves and then refold the denatured
protein.
The Refolding Process Goes through Independent Steps--
This and
the subsequent experiments were carried out with carbonic anhydrase
only because with a relatively small monomeric protein the results
would be easier to interpret. To check whether these two RNA moieties
reacted independently or not, we added one of them to denatured
carbonic anhydrase, waited for 15 min, and then added the other.
Following an additional incubation of 30 min, the enzyme activity was
assayed. We found recovery of enzyme activity only when the order of
addition was RNA1 followed by RNA2. We could wait for a sufficiently
long time, even more than 1 h, after adding RNA1 and then add
RNA2. The final recovery of activity was the same as the recovery with
the two RNA molecules added together in unimolecular ratio. Fig.
4 shows that the enzyme activity
recovered when RNA1 was added first, but did not do so when RNA2 was
added first. The total concentration of RNA varied in different sets,
but the ratio of the RNA moieties was always maintained as 1:1. As
shown in Fig. 4, maximum recovery of enzyme activity was obtained when
the ratio of enzyme (33 nM):RNA (unimolecular mixture of
RNA1 and RNA2) was 1:1. There was slight inhibition in the recovery at
higher RNA concentration (6, 9, 10). Fig.
5 shows the time course of recovery of
enzyme activity in an experiment where RNA2 concentration varied. Here
the RNA1 was added in equimolar ratio with the denatured enzyme (132 nM), and RNA2 was added after 15 min in different molar
ratios of RNA1:RNA2, from 1:1 to 1:1/8. As is apparent from Fig.
5A, the RNA1-bound enzyme was not active. About 20% enzyme
activity, which appears in presence of RNA1 only, was about the same as
the recovery of activity without ribosomal assistance. This might be
due to the enzyme molecules, which failed to bind to RNA1 but went
straight to the true pathway of spontaneous folding. RNA-assisted
recovery of activity was seen after RNA2 was added. The maximum
recovery of activity was the same irrespective of the concentration of RNA2, the only difference being the rate of the recovery of enzyme activity, which was slower with lower concentration of RNA2. A quick
gel filtration assay with the sample where RNA1:RNA2 ratio was 1:1
showed that the enzyme dissociated from RNA before its activity reached
its peak. This showed that the dissociated folding intermediates could
be protected by RNA and then released on the true folding pathway. All
these time courses of recovery of enzyme activity with different
concentrations of RNA2 could be plotted in a linear logarithmic plot,
showing that they represented first order reaction (Fig.
5B). On the other hand, the first step of the refolding
reaction (the binding of denatured enzyme to RNA1, which gave a stable
RNA-bound folding intermediate) was obviously a first order reaction
with respect to enzyme concentration, but it was too fast to be
considered as the rate-limiting step in the overall refolding reaction.
It should be mentioned here that we cannot vary the concentration of
RNA1 below the level of enzyme concentration. In fact, we need it in
5-fold excess of denatured enzyme molecules to bind all of
them.2
Release of the Folding Intermediate from RNA1 by
Detergent/Ethanol--
The RNA2 could be just competing with the
protein folding intermediate to bind to RNA1 so that the latter was
displaced, or RNA2 could play an active role in the process of folding
the RNA1-bound denatured protein and then release it. To distinguish
between these two possibilities, we added small quantities of non ionic detergent Triton X-100 (final concentration 0.2%) or ethanol (final concentration 3%) to the RNA1-bound carbonic anhydrase (100 nM). In both the cases, the enzyme dissociated from RNA1
and, like the RNA2-mediated released enzyme, folded slowly to active
form although the recovery of activity was slightly less than the
RNA2-mediated process, as shown in Fig. 5C. The small amount
of ethanol and Triton X-100 had no effect on the activity of enzyme.
Therefore, the RNA2 did not play any active role in folding denatured
carbonic anhydrase. Its function was to release the protein so that it could fold to active form by itself. This puts the RNA1, which is
basically the large central loop of the domain V of 23 S rRNA, at the
center stage of protein folding. This 337-nt-long RNA could possibly
trap the protein folding intermediates at a stage where misfolding due
to non-native interactions of its different segments would lead to loss
of enzyme activity. A simple reduction in the non-native interactions
of different protein segments might ensure the formation of on-pathway
folding intermediates. The experiments below show that the RNA1-bound
denatured enzyme was a true intermediate in this process of folding.
Stable Association of the Denatured Enzyme with the
RNA1--
During refolding, the denatured carbonic anhydrase remained
bound as a stable intermediate with RNA1 and this RNA-enzyme complex could be recovered by gel filtration through Sephadex G-100 column. The
RNA and protein were labeled with [ Gel Retardation Assay on Denatured Carbonic Anhydrase-bound
RNA1--
We have also seen the stable binding of the refolding
carbonic anhydrase to RNA1 in 5% polyacrylamide gel. As shown in Fig. 6B, the enzyme-bound RNA1 (50 nM enzyme:25
nM RNA1) migrated slower than the control unbound RNA1.
When the enzyme was released by treatment with 1% SDS, RNA1 migrated
to the same position as its control. RNA1 was added at half the enzyme
concentration to ensure that both the enzyme-bound as well as free RNA1
could be detected in the gel. To bind all RNA1 molecules, the enzyme
concentration should be about 5 times that of RNA1 (data not shown).
Recently, we have developed a filter binding assay where the RNA1 gets
trapped on the filter only when it is bound by the refolding protein.
Therefore, the binding to and the release of the protein from RNA1 can
be quantitated. This would help to select mutants of RNA1, made by
site-directed mutagenesis, which are deficient in binding/refolding
proteins. We have preliminary observation with one such mutant, which
is defective in binding/refolding denatured carbonic
anhydrase.2 We are thus in the process of identifying
nucleotides in RNA1 that directly interact with the protein or ensure
its binding to RNA1.
Fluorescence Studies on the Tertiary Organization of Native and
Refolding Carbonic Anhydrase--
Carbonic anhydrase has six
tryptophan residues (16), which fluoresce strongly in the native enzyme
when excited at 290 nm. We used this strong fluorescence emission,
which peaks at around 330 nm, to probe the tertiary organization of the
protein during denaturation and refolding. As shown in Fig.
7A, the tryptophan fluorescence quenched dramatically when the denatured protein was bound
to RNA1. The intensity of emission increased quickly as soon as RNA2
was added. This was due to the release of the bound enzyme, and its
time course is shown in inset of Fig. 7A. The
released enzyme was not active but took some time (presumably for fine
tuning of the active site) to show its activity (Fig. 7B). A
quick spin column gel filtration assay after adding RNA2 but before the
appearance of enzyme activity also showed that the enzyme dissociated
from RNA1 (data not shown). Combining this with results of gel
filtration experiments (shown in Fig. 6A), we thus see that
most of the denatured protein molecules bound to RNA1 were destined to
go through on-pathway folding intermediates by themselves to be active
once they were released by RNA2. The activity appeared after the
release from RNA1 supported the studies, which suggested that bacterial
proteins mostly fold posttranslationally (1, 17, 18). We then made a
comparative study on the tertiary structures of the native,
self-folded, RNA1-bound, and RNA-mediated folded enzyme, using the
tryptophan accessibility of the quencher acrylamide in case of all the
forms. As shown in Fig. 8, the tryptophan accessibility of the quencher was 100% for the native, self-folded, and RNA-mediated folded proteins. However, the accessibility was lower
for the RNA1-bound denatured enzyme. Some of the tryptophans were thus
inaccessible to the quencher, presumably because they were blocked by
binding of the RNA1 with the folding intermediates. The difference in
the slope of the Lehrer plot for native/self-folded and
RNA-bound/released enzyme was due to the fact that greater amount of
protein was taken in the first case. This was done to obtain higher
fluorescence signal. In case of RNA-bound/released enzyme, we had to
work with lower concentrations to avoid inner filter problems that
could arise at high RNA concentration.
The studies on protein folding by modulators like E. coli ribosome, its 23 S rRNA, and the domain V of bacterial 23 S
rRNA were all done with stoichiometric amount of these modulators with respect to protein concentration. This was due to the following compulsion. If all the denatured protein molecules were not sequestered by the folding modulators as soon as the denaturant was diluted out,
the unbound protein molecules would go through spontaneous folding mode
(both on and off pathways) and the yield of refolded protein would go
down. Ideally, all the denatured protein molecules should have been
sequestered by the modulator. We could achieve this sort of stable
association of the refolding protein with RNA1 of domain V of 23 S
rRNA. In fact, with a mole to mole ratio of 5:1 for RNA1: protein
molecules, we could trap all the folding intermediates on RNA1 (data
not shown). For ribosomal particle, 23 S rRNA, and 660-nt domain V RNA,
this mole to mole ratio could not be increased much above 1:1 since
that would reduce the extent of folding (6, 9, 10). This could be due
to the RNA2 region competing with RNA1 for the denatured protein
instead of allowing the RNA1 to bind the folding intermediate first. We
think that since only one domain of 23 S rRNA molecule (the domain V)
could interact with newly synthesized protein in vivo, the
question of a stoichiometry lower or higher than 1 does not arise.
Therefore, the mechanism of protein folding by ribosome and ribosomal
RNA should be considered strictly within the stoichiometric
relationship and it would not make sense to use ribosome/ribosomal RNA
in large excess or in catalytic amount; however, when we could break
the reaction in two parts, the RNA2 could obviously be added in
catalytic amount, and it did turn over to give higher yield of refolded protein with time.
Within a very short period after diluting out the denaturant, the
protein reforms its secondary structure. We saw that a delay of 10-15
s in adding the modulator after diluting out the denaturant did not
reduce reactivation of a number of proteins noticeably (data not
shown). The secondary structures must have been completely formed
within this time. Therefore, some spontaneously folding intermediates
beyond the level of secondary structure formation should be the
substrate for ribosome-assisted folding. This agrees with in
vivo studies and studies on transcription-translation process in
cell-free extract, where the polypeptides have been shown to take up
secondary structure during synthesis on the ribosome (19-23). At this
state, the polypeptide is trapped by RNA1. The binding is stronger at
higher salt concentration and could be mainly due to hydrophobic nature
of the interaction between denatured protein and RNA1. When released by
RNA2, most of the folding intermediates by themselves turn into active
protein and there is no more loss of activity due to off-pathway
folding. This implies that the dissociated intermediates must be the
on-pathway folding intermediates, which would all end up as active
protein. This last, relatively slow step appears to be the
rate-limiting step in this reaction. It is basically a first order
reaction with respect to protein concentration. Therefore, the overall
reaction is the result of the following independent events:
(a) very fast binding of refolding intermediate to RNA1,
(b) slow release of folding intermediates from RNA1 by RNA2,
and (c) self-folding of the released on-pathway folding
intermediates. This third step is the slowest one. The situation
corresponds to posttranslational protein folding in vivo,
believed to be mainly true in bacteria (17, 18). We have also observed
such slow posttranslational formation of active Thus, the 337-nt-long domain V region of 23 S rRNA directs protein
folding intermediates to take up the active tertiary structure by
themselves. This region of ribosomal RNA turns out to be the most
conserved one in terms of the base sequences and secondary structure in
course of evolution from unicellular to multicellular organisms. This
could be the primordial RNA, which helped spontaneously synthesized
polypeptides to fold and be selected for biological activities in
course of even pre cellular evolution. Even the large rRNAs in
mitochondria from various sources that are considerably smaller than
their bacterial and eukaryotic counterpart posses this stretch of
domain V, while other region of domain V (for example the RNA2 part)
appears to be missing in them. Thus, this 337-nt RNA might represent
the basic molecular fossil (32) that has been carrying out the process
of trapping protein folding intermediates to shunt more newly
synthesized protein molecules to the activation pathway. While the RNA1
and a small part of RNA2 are present in the mitrochondrial ribosome,
both the RNA1 and the RNA2 stretches are present in 23 S rRNAs, whereas
even larger stretches of nucleotides are present in more evolved 26 and
28 S rRNAs.
An extension of this study with mitochondrial, bacterial, and
eukaryotic large ribosomal RNA segments could throw more light on the
interaction of these RNAs with proteins and the evolution of the
protein folding activity.
As mentioned in the text, we are now collecting mutants in RNA1 by
site-directed mutagenesis so that the nucleotides that directly
interact with the proteins or ensure their binding to RNA1 can be
identified to understand the role of domain V RNA in ribosome-assisted
protein folding.
We acknowledge the help of Distributed
Information Center of this department. We thank Dr. D. Pal for critical
reading of the manuscript.
*
This work was supported in part by CSIR Grant 37/0935/97
EMR-II and DBT Grant BT-TF/15/15/91.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
CSIR senior research fellow.
¶
UGC junior research fellow.
2
S. Chowdhury, S. Pal, S. Chandra, D. Sarkar,
A. N. Ghosh, and C. Das Gupta, unpublished observation.
The abbreviations used are:
nt, nucleotide(s);
FITC, fluorescein isothiocyanate.
Complementary Role of Two Fragments of Domain V of 23 S
Ribosomal RNA in Protein Folding*
§,
,
¶,
,

Department of Biophysics, Molecular Biology
and Genetics, University College of Science and Technology, University
of Calcutta, 92 Acharya Prafulla Chandra Road, Calcutta 700009, India,
the
Division of Biology and Medicine, Brown University,
Providence, Rhode Island 02912, and the ** National Institute of Cholera
and Enteric Diseases, Calcutta 700010, India
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-lactamase, carbonic anhydrase,
-galactosidase, etc.) (1-6). This in vitro protein folding activity has
been found to reside in the domain V of the 23 S rRNA in 50 S particle of the ribosome. This activity of ribosome has also been identified in vivo by showing slow posttranslational activation of the
enzyme
-galactosidase in Escherichia coli that was
synthesized just prior to the addition of the 30 S specific protein
synthesis inhibitors kasugamycin and streptomycin. This
posttranslational activation, however, was immediately arrested by
adding antibiotics that bind to domain V of 23 S rRNA of 50 S ribosomal
particle (1). The important question then is whether biological
entities like molecular chaperons (7, 8) and ribosomes fold proteins to
their active states following a pathway basically similar to
spontaneous folding or whether there will there be a paradigm shift in
our understanding of protein folding in the cell when we know how
ribosome (2-6, 9-11), which synthesizes the polypeptide, also folds
it to active form.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-32P]UTP with the ribonucleotides and measuring its
incorporation in RNA. We call the 337- and 425-nt-long RNA molecules
RNA1 and RNA2, respectively (see Fig. 2).
-32P]UTP to prepare 32P-labeled
337-nt-long RNA1, the DNA template was destroyed, and then the RNA was
purified by phenol extraction and ethanol precipitation. Denatured
carbonic anhydrase was added in refolding buffer containing this
radiolabeled RNA1 at 25 °C. The concentrations of RNA1 and the
enzyme were 25 and 50 nM, respectively. All RNA1 molecules would not be trapped by the enzyme at this concentration. The enzyme-RNA1 complex was divided in two equal parts. One part was loaded
on a 5% native polyacrylamide gel, and the other part was treated with
1% SDS at 50 °C for 15 min and loaded on the same gel. The gel was
run in TBE buffer and exposed to x-ray film for autoradiography.
F) = 1/(Ksv·fe·(Q)
+1/fe (12), where fe is
the fraction of total number of tryptophan residues in carbonic
anhydrase accessible to the quencher, F0 is the
fluorescence intensity in absence of the quencher, F is the
fluorescence intensity at the quencher concentration Q, and
Ksv is Stern-Volmer quenching constant assuming purely dynamic quenching.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (20K):
[in a new window]
Fig. 1.
Reactivation of denatured lactate
dehydrogenase (A), malate dehydrogenase
(B), and human carbonic anhydrase I
(C) with 50 S ribosomal subunit (
), 23 S ribosomal
RNA (
), and 660-nt domain V of 23 S rRNA (
).

View larger version (15K):
[in a new window]
Fig. 2.
Secondary structures of different segments of
domain V of bacterial 23 S ribosomal RNA, 337-nt RNA1
(A), 425-nt RNA2 (B), and 660-nt
total domain V region (C). The bases shown in the
loop in A were introduced to join the stem by Kovalic
et al. (15). They do not belong to the authentic domain V of
23 S rRNA.

View larger version (16K):
[in a new window]
Fig. 3.
Reactivation of denatured lactate
dehydrogenase (
), malate dehydrogenase (
), and human carbonic
anhydrase I (
) with different amounts of 1:1 mixture of RNA1 and
RNA2.

View larger version (16K):
[in a new window]
Fig. 4.
Activity of denatured carbonic anhydrase
after sequential incubation with equal concentration of RNA1 and
RNA2. Recovery of enzyme activity was seen when RNA2 was added 15 min after addition of RNA1 (
), but there was no recovery of activity
when RNA1 was added 15 min after addition of RNA2 (
). An additional
incubation of 30 min was done before measuring enzyme activity after
adding RNA2 and RNA1, respectively, in the above cases.

View larger version (18K):
[in a new window]
Fig. 5.
A, recovery of activity of denatured
carbonic anhydrase when RNA1 was added to it (
), followed by RNA2 at
mole to mole ratio of RNA1: RNA2 of 1:1 (
), 1:1/2 (
), 1:1/4
(
), and 1:1/8 (
). B, first order plot with the same
symbols as in the time course of recovery shown in A.
C, time course of recovery of activity of RNA1-bound
denatured carbonic anhydrase when released by 0.2% Triton X-100 (
)
and 3% ethanol (
).
-32P]UTP and FITC,
respectively. The FITC helped to quantitate the enzyme even at low
concentration which was used in these experiments irrespective of
whether it was in native or in denatured state. A part of the
RNA-protein complex was loaded on the column. As shown in Fig.
6A, the complex eluted out in
the void volume whereas a small fraction of unbound enzyme was retained
in the column and eluted later in the same fraction as the native
enzyme (Fig. 6A, c). The RNA-bound enzyme in void
volume showed no activity. The small amount of unbound enzyme could
have gone through the process of spontaneous folding and its activity
was too small to measure (spontaneous folding was 20% in such
experiments). To the remaining RNA-bound enzyme, RNA2 was added at a
ratio of protein:RNA as 1:1/8. After incubation for 1 h, the
enzyme activity was assayed and the reaction mixture was loaded on the
same column. As shown in the elution profile (Fig. 6A,
d), the reactivated enzyme dissociated from the RNA1 and
eluted at the same position as the native enzyme. Here, the total count
in the RNA in void volume was equal to the sum of counts in RNA1 and
RNA2. More than 80% of the refolded enzyme activity was found in the
protein peak. Very little enzyme remained associated with RNA in the
void volume. Therefore, the RNA1 keeps the folding intermediates of the
enzyme tightly bound, which can be dissociated from it by RNA2 before or after refolding. If it is dissociated before refolding, the intermediate must fold spontaneously, i.e. it must be an
on-pathway intermediate for spontaneous folding. In such a case the
role of RNA1and RNA2 could be rather passive, that of protecting the folding intermediates against the forces of misfolding. In any event,
the RNA-bound protein gave a stable intermediate in this refolding
pathway that should be thoroughly characterized.

View larger version (17K):
[in a new window]
Fig. 6.
A, Sephadex G-100 gel filtration profile
of native carbonic anhydrase (a), 32P-labeled
RNA1 (b), 32P-labeled RNA1-bound denatured
carbonic anhydrase (c), and carbonic anhydrase released from
32P-labeled RNA1 after addition of RNA2 (d).
Carbonic anhydrase was labeled with FITC and quantitated from
fluorescence emission intensity at 520 nm when excited at 495 nm. FITC
labeling was necessary to quantitate very small amount of enzyme used
in these experiment. B, gel retardation assay on 5%
polyacrylamide gel of denatured carbonic anhydrase-bound RNA1.
Lane 1, RNA1 only; lane 2,
RNA1 bound to denatured enzyme; lane 3, sample of
lane 2 treated with 1% SDS at 50 °C.

View larger version (24K):
[in a new window]
Fig. 7.
Gradual increase in intensity of tryptophan
fluorescence emission peak (A) and the activity of
carbonic anhydrase (B) after addition of RNA2- to
RNA1-bound denatured enzyme. The mole to mole ratio of RNA1: RNA2
was 1:1/4. The inset in A shows the increase in
fluorescence emission with time from the initial value
Fo.

View larger version (18K):
[in a new window]
Fig. 8.
Lehrer plot of acrylamide quenching of
tryptophan fluorescence of carbonic anhydrase. Native enzyme
(
), self-folded enzyme (
), RNA1-bound denatured enzyme (
), and
refolded enzyme after release from RNA1 by RNA2 (
). The enzyme
concentrations were higher in the first two cases and lower in the
remaining two samples (see text).
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-galactosidase in
E. coli several minutes after the stoppage of synthesis of
the protein by translation inhibiting antibiotics (1). It should be
emphasized, however, that this posttranslational folding could be
"guided" by the translational machinery, like ribosomal RNA (1, 3,
4, 6, 9, 10) and protein like EFTu. (24). Several studies on
conformation of nascent proteins on ribosomes and the contribution of
ribosome in their folding process point to similar possibilities (17,
20, 21, 23, 25-30). A number of studies were done in the laboratory of Brimacombe (31), where aminoacylated initiator tRNA and peptidyl tRNA
of different lengths obtained by coupled transcription-translation of
N-terminal part of different lengths of E. coli ompA
protein, bacteriophage T4 gene 60 protein, and tetracycline resistance gene product were photo-cross-linked to the ribosome. After
deproteinization, the amino acid and short polypeptides were found to
be cross-linked with many bases in the large loop of domain V and with
few other bases outside the domain V of 23 S rRNA. Thus, the
association of nascent polypeptide mainly with domain V of 23 S rRNA is
well established. The role of RNA2 in the process of protein folding is
in releasing the refolding intermediates and this passive role can be
mimicked by 0.2% Triton X-100 or 3% ethanol, which reduce the solvent
polarity and weaken hydrophobic interaction.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES

To whom correspondence should be addressed. Tel.:
91-33-351-0359; Fax: 91-33-337-6839; E-mail:
ckdg@cubmb.ernet.in.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Chattopadhyay, S.,
Pal, S.,
Chandra, S.,
Sarkar, D.,
and DasGupta, C.
(1999)
Biochim. Biophys. Acta
1429,
293-298[CrossRef][Medline]
[Order article via Infotrieve]
2.
Das, B.,
Chattopadhyay, S.,
and DasGupta, C.
(1992)
Biochem. Biophys. Res. Commun.
183,
774-980[CrossRef][Medline]
[Order article via Infotrieve]
3.
Chattopadhyay, S.,
Das, B.,
Bera, A. K.,
and DasGupta, C.
(1994)
Biochem. J.
300,
717-721
4.
Bera, A. K.,
Das, B.,
Chattopadhyay, S.,
and DasGupta, C.
(1994)
Curr. Sci.
66,
230-262
5.
Bera, A. K.,
Das, B.,
Chattopadhyay, S.,
and DasGupta, C.
(1994)
Biochem. Mol. Biol. Int.
32,
315-323[Medline]
[Order article via Infotrieve]
6.
Das, B.,
Chattopadhyay, S.,
Bera, A. K.,
and Dasgupta, C.
(1996)
Eur. J. Biochem.
235,
613-621[Medline]
[Order article via Infotrieve]
7.
Hartl, F. U.,
and Martin, J.
(1992)
Annu. Rev. Biophys. Biomol. Struct.
21,
293-322[CrossRef][Medline]
[Order article via Infotrieve]
8.
Gething, M. J.,
Blond, E. S.,
Buchner, A,
Fourie, A.,
Knarr, G.,
Modrow, S.,
Nanu, L.,
Segal, M.,
and Sambrook, J.
(1995)
Cold Spring Harbor Symp. Quant. Biol.
60,
417-428 9.
Chattopadhyay, S.,
Das, B.,
and DasGupta, C.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
8284-8287 10.
Pal, D.,
Chattopadhyay, S.,
Chandra, S.,
Sarkar, D.,
Chakrabarty, A.,
and DasGupta, C.
(1997)
Nucleic Acids Res.
25,
5047-5051 11.
Kudlicki, W.,
Coffman, A.,
Kramer, G.,
and Hardesty, B.
(1997)
Folding Design
2,
101-108[CrossRef][Medline]
[Order article via Infotrieve]
12.
Lehrer, S. S.
(1971)
Biochemistry
10,
3254-3263[CrossRef][Medline]
[Order article via Infotrieve]
13.
Noller, H. F.,
Hoffarth, V.,
and Zimniak, Z.
(1992)
Science
256,
1416-1419 14.
Nitta, I.,
Kamada, Y.,
Noda, H.,
Veda, T.,
and Watnabe, K.
(1998)
Science
281,
666-669 15.
Kovalic, D.,
Giannattasio, R. B.,
and Weisblum, B.
(1995)
Biochemistry
34,
15838-15844[CrossRef][Medline]
[Order article via Infotrieve]
16.
Barlow, H. J.,
Lowe, N.,
Edwards, H. Y.,
and Butterworth, P. H. W.
(1987)
Nucleic Acids Res.
15,
2386 17.
Netzer, W. J.,
and Hartl, F. U.
(1997)
Nature
355,
33-34
18.
Netzer, W. J.,
and Hartl, F. U.
(1998)
Trends Biochem. Sci.
23,
68-73[CrossRef][Medline]
[Order article via Infotrieve]
19.
Fedorov, A. N.,
Friguet, B.,
Djavadi-Ohaniance, L.,
Alaknov, Y.,
and Goldberg, M. E.
(1992)
J. Mol. Biol.
228,
351-358[CrossRef][Medline]
[Order article via Infotrieve]
20.
Kudlicki, W.,
Odom, O. W.,
Kramer, G.,
and Hardesty, B.
(1994)
J. Mol. Biol.
244,
319-331[CrossRef][Medline]
[Order article via Infotrieve]
21.
Kudlicki, W.,
Odom, O. W.,
Kramer, G.,
and Hardesty, B.
(1994)
J. Biol. Chem.
269,
16549-16553 22.
Federov, A. N.,
and Baldwin, T. O.
(1997)
J. Biol. Chem
272,
32715-32718 23.
Komar, A. A.,
Kommer, A.,
Krasheninnikov, I. A.,
and Spirin, A. S.
(1997)
J. Biol. Chem.
72,
10646-10651
24.
Kudlicki, W.,
Coffman, A.,
Kramer, G.,
and Hardesty, B.
(1997)
J. Biol. Chem.
272,
32206-32210 25.
Hendrik, J. P.,
Langer, T.,
Davis, T. A.,
Hartl, F. U.,
and Wiedmann, M.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
10216-10220 26.
Hansen, W. J.,
Lingappa, V. R.,
and Welch, W. J.
(1994)
J. Biol. Chem.
269,
26610-26613 27.
Hartl, F. U.,
Holden, R.,
and Langer, T.
(1994)
Trends Biochem. Sci.
19,
20-25[CrossRef][Medline]
[Order article via Infotrieve]
28.
Hardesty, B.,
Kudlicki, W.,
Odam, O. W.,
Zhang, T. R.,
McCarthy, D.,
and Kramer, G.
(1995)
Biochem. Cell Biol.
73,
1199-1207[Medline]
[Order article via Infotrieve]
29.
Fedorov, A. N.,
and Baldwin, T. O.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
1227-1231 30.
Ellis, R. J.,
and Hartl, F. U.
(1996)
FASEB J.
22,
20-26
31.
Choi, M. K.,
and Brimacombe, R.
(1998)
Nucleic Acids Res.
26,
887-895 32.
Maizels, N.,
and Weiner, A.
(1993)
The RNA World
, pp. 577-602, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
D. Samanta, D. Mukhopadhyay, S. Chowdhury, J. Ghosh, S. Pal, A. Basu, A. Bhattacharya, A. Das, D. Das, and C. DasGupta Protein Folding by Domain V of Escherichia coli 23S rRNA: Specificity of RNA-Protein Interactions J. Bacteriol., May 1, 2008; 190(9): 3344 - 3352. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Raine, M. Lovmar, J. Wikberg, and M. Ehrenberg Trigger Factor Binding to Ribosomes with Nascent Peptide Chains of Varying Lengths and Sequences J. Biol. Chem., September 22, 2006; 281(38): 28033 - 28038. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Sanyal, S. Pal, S. Chaudhuri, and C. DasGupta 23S rRNA assisted folding of cytoplasmic malate dehydrogenase is distinctly different from its self-folding Nucleic Acids Res., June 1, 2002; 30(11): 2390 - 2397. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chowdhury, S. Pal, J. Ghosh, and C. DasGupta Mutations in domain V of the 23S ribosomal RNA of Bacillus subtilis that inactivate its protein folding property in vitro Nucleic Acids Res., March 1, 2002; 30(5): 1278 - 1285. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Manna, T. Sarkar, A. Poddar, M. Roychowdhury, K. P. Das, and B. Bhattacharyya Chaperone-like Activity of Tubulin. BINDING AND REACTIVATION OF UNFOLDED SUBSTRATE ENZYMES J. Biol. Chem., October 19, 2001; 276(43): 39742 - 39747. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Clark and J. King A Newly Synthesized, Ribosome-bound Polypeptide Chain Adopts Conformations Dissimilar from Early in Vitro Refolding Intermediates J. Biol. Chem., June 29, 2001; 276(27): 25411 - 25420. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||